Paul Kelly

Insider Reports History

Entity
Individual
Location
300 East 56 Th Street, Apt 19 E, New York,, NY
Signature
/s/ Paul Kelly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Kelly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RELMADA THERAPEUTICS, INC. Director Common Stock 212K $550K $2.59 Sep 9, 2024 Direct
RELMADA THERAPEUTICS, INC. Director Stock Option (right to buy) 65.7K May 24, 2024 Direct

Insider Reports Filed by Paul Kelly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RLMD RELMADA THERAPEUTICS, INC. Sep 9, 2024 1 $64.8K 4 Sep 11, 2024 Director
RLMD RELMADA THERAPEUTICS, INC. May 24, 2024 2 $0 4 May 29, 2024 Director
RLMD RELMADA THERAPEUTICS, INC. Dec 15, 2023 1 $0 4 Dec 19, 2023 Director
RLMD RELMADA THERAPEUTICS, INC. May 25, 2023 1 $0 4 May 30, 2023 Director
RLMD RELMADA THERAPEUTICS, INC. Dec 31, 2022 4 $0 5 Feb 2, 2023 Director
RLMD RELMADA THERAPEUTICS, INC. Dec 16, 2022 1 $0 4 Dec 20, 2022 Director
RLMD RELMADA THERAPEUTICS, INC. Apr 4, 2022 3 -$268K 4 Apr 5, 2022 Director
RLMD RELMADA THERAPEUTICS, INC. Jan 3, 2022 2 -$64.8K 4 Jan 5, 2022 Director
RLMD RELMADA THERAPEUTICS, INC. Dec 17, 2021 1 $0 4 May 26, 2022 Director
RLMD RELMADA THERAPEUTICS, INC. Dec 17, 2021 1 $0 4 Dec 21, 2021 Director